Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression

被引:45
作者
Ioannides, Zara A. [1 ,3 ]
Ngo, Shyuan T. [1 ,4 ,5 ]
Henderson, Robert D. [2 ,3 ]
McCombe, Pamela A. [1 ,2 ,3 ]
Steyn, Frederik J. [1 ,4 ]
机构
[1] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia
[2] Univ Queensland, Sch Med, Herston, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Neurol, Herston, Qld, Australia
[4] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia
[5] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia
基金
英国医学研究理事会;
关键词
Amyotrophic lateral sclerosis; Motor neurone disease; Metabolism; Neurometabolism; Nutrition; Energy expenditure; BODY-MASS INDEX; G93A-SOD1 MOUSE MODEL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; GUT MICROBIOTA; CARBOHYDRATE-METABOLISM; PREDICTIVE EQUATIONS; NUTRITIONAL-STATUS; DIABETES-MELLITUS; SKELETAL-MUSCLE; GASTROINTESTINAL DYSFUNCTION;
D O I
10.1159/000446502
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the death of motor neurones, which leads to paralysis and death in an average of 3 years following diagnosis. The cause of ALS is unknown, but there is substantial evidence that metabolic factors, including nutritional state and body weight, affect disease progression and survival. This review provides an overview of the characteristics of metabolic dysregulation in ALS focusing on mechanisms that lead to disrupted energy supply (at a whole-body and cellular level) and altered energy expenditure. We discuss how a decrease in energy supply occurs in parallel with an increase in energy demand and leads to a state of chronic energy deficit which has a negative impact on disease outcome in ALS. We conclude by presenting potential and tested strategies to compensate for, or correct this energy imbalance, and speculate on promising areas for further research. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:382 / 397
页数:16
相关论文
共 187 条
[1]   Brain Regulation of Appetite and Satiety [J].
Ahima, Rexford S. ;
Antwi, Daniel A. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (04) :811-+
[2]   Body mass index delineates ALS from FTD: implications for metabolic health [J].
Ahmed, R. M. ;
Mioshi, E. ;
Caga, J. ;
Shibata, M. ;
Zoing, M. ;
Bartley, L. ;
Piguet, O. ;
Hodges, J. R. ;
Kiernan, M. C. .
JOURNAL OF NEUROLOGY, 2014, 261 (09) :1774-1780
[3]   Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism [J].
Ahmed, Rebekah M. ;
Irish, Muireann ;
Piguet, Olivier ;
Halliday, Glenda M. ;
Ittner, Lars M. ;
Farooqi, Sadaf ;
Hodges, John R. ;
Kiernan, Matthew C. .
LANCET NEUROLOGY, 2016, 15 (03) :332-342
[4]   Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model [J].
Ari, Csilla ;
Poff, Angela M. ;
Held, Heather E. ;
Landon, Carol S. ;
Goldhagen, Craig R. ;
Mavromates, Nicholas ;
D'Agostino, Dominic P. .
PLOS ONE, 2014, 9 (07)
[5]   ANTECEDENT MEDICAL DISEASES IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - A POPULATION-BASED CASE-CONTROLLED STUDY IN ROCHESTER, MINN, 1925 THROUGH 1987 [J].
ARMON, C ;
KURLAND, LT ;
OBRIEN, PC ;
MULDER, DW .
ARCHIVES OF NEUROLOGY, 1991, 48 (03) :283-286
[6]   Host-bacterial mutualism in the human intestine [J].
Bäckhed, F ;
Ley, RE ;
Sonnenburg, JL ;
Peterson, DA ;
Gordon, JI .
SCIENCE, 2005, 307 (5717) :1915-1920
[7]   Autonomic impairment in amyotrophic lateral sclerosis [J].
Baltadzhieva, R ;
Gurevich, T ;
Korczyn, AD .
CURRENT OPINION IN NEUROLOGY, 2005, 18 (05) :487-493
[8]   The ketogenic diet: Uses in epilepsy and other neurologic illnesses [J].
Barañano K.W. ;
Hartman A.L. .
Current Treatment Options in Neurology, 2008, 10 (6) :410-419
[9]   Differential gene expression profiling of short and long term denervated muscle [J].
Batt, J ;
Bain, J ;
Goncalves, J ;
Michalski, B ;
Plant, P ;
Fahnestock, M ;
Woodgett, J .
FASEB JOURNAL, 2005, 19 (13) :115-+
[10]   CD4+T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS [J].
Beers, David R. ;
Henkel, Jenny S. ;
Zhao, Weihua ;
Wang, Jinghong ;
Appel, Stanley H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (40) :15558-15563